Global communications firm, Edelman has appointed Kate Hawker as healthcare managing director
She has over 25 years’ experience working within the biopharmaceutical sector, covering a variety of therapeutic areas for global, EMEA and UK clients that have included AstraZeneca, GlaxoSmithKline and Novartis.
She said: “Edelman boasts a prestigious health team with an enviable client roster and vibrant team culture.
“There remains a relentless ambition to innovate and to offer ‘best in class’ creative approaches to deliver great work for our clients.
“There is more to achieve, and I am thrilled to be joining at this time.”
Formerly healthcare chair at Burson-Marsteller, Hawker has a background in healthcare communications serving the likes of InforMed, and Fleishman-Hillard, and founding in 2000 medical communications agency The Remedy.
Matt Hurst, chief operating officer for Edelman UK, said: “Kate’s ability to develop and execute effective campaigns creatively within regulatory and legal frameworks is impressive.
“Her skills and leadership experience will be very valuable to our clients as we continue to build integrated programmes.”